Churg-Strauss syndrome with eosinophil cationic protein in a 39-year old woman

被引:4
|
作者
Behrens, R
Holzhausen, HJ
von Poblozki, A
Stephan, M
Kampfe, D
Schwartze, G
Fleig, WE
机构
[1] Univ Halle Wittenberg, Klin & Poliklin Innere Med 1, D-06097 Halle, Germany
[2] Univ Halle Wittenberg, Neurol Klin, D-06097 Halle, Germany
[3] Univ Halle Wittenberg, Inst Pathol, D-06097 Halle, Germany
[4] Univ Halle Wittenberg, Dermatol Klin, D-06097 Halle, Germany
关键词
D O I
10.1055/s-2007-1023891
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
History and clinical findings: A 39-year-old woman in good health suddenly developed painful paraesthesia and incomplete paresis of all four limbs. Furthermore, arterial hypertension and tachycardia were found. The patient reported a history of chronic allergic rhinitis for 10 years and asthma one year. Investigations: Laboratory data showed an increased leucocyte count with a substantial increase in eosinophils in peripheral blood as well as in bone marrow. Nonspecific inflammatory markers such as erythrocyte sedimentation rate, C-reactive protein, fibrinogen as well as eosinophil cationic protein (ECP) were also increased. Histological investigations of a skin-muscle biopsy of the quadriceps revealed necrotizing vasculitis with extravascular granulomata and histocytic giant cells, Diagnosis, treatment and course: Based on the diagnosis of Churg-Strauss syndrome treatment with methylprednisolone (500 mg every second day) was started, but was found to be ineffective after 10 days. Symptoms responded well to a subsequent course of 150 mg cyclophosphamide combined with 50 mg prednisolone per day. Pareses and pain were significantly reduced and all qualitative nerve functions returned to normal within two weeks of treatment. Laboratory parameters, especially the ECP, were similarly normalized. Conclusion: Churg-Strauss syndrome should be considered in the differential diagnosis of unexplained polyneuropathy. Determination of ECP may not only help in the diagnosis but does also facilitate monitoring of treatment and of further course of the disease.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 50 条
  • [31] Montelukast and Churg-Strauss syndrome
    Conen, D
    Leuppi, R
    Bubendorf, L
    Ronsdorf, A
    Tamm, M
    Hauser, T
    SWISS MEDICAL WEEKLY, 2004, 134 (25-26) : 377 - 380
  • [32] Montelukast and the Churg-Strauss syndrome
    Wechsler, ME
    Finn, D
    Jordan, M
    Gunawardena, D
    Drazen, JM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A641 - A641
  • [33] Omalizumab and Churg-Strauss syndrome
    Stanciu, A.
    Ruppert, A.
    Averous, G.
    Poindron, V
    Martin, T.
    Debry, C.
    Pauli, G.
    de Blay, F.
    ALLERGY, 2008, 63 : 560 - 561
  • [34] Rituximab in Churg-Strauss syndrome
    Koukoulaki, M
    Smith, KGC
    Jayne, DRW
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (04) : 557 - 559
  • [35] Omalizumab and Churg-Strauss syndrome
    Giavina-Bianchi, Pedro
    Giavina-Bianchi, Mara
    Agondi, Rosana
    Kalil, Jorge
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (01) : 217 - 217
  • [36] Interleukins in Churg-Strauss syndrome
    Kurosawa, M
    Nakagami, R
    Morioka, J
    Inamura, H
    Mizushima, Y
    Sugawara, N
    Yamashita, T
    Yokoseki, T
    Kitamura, S
    Omura, Y
    Shibata, M
    Chihara, J
    ALLERGY, 2000, 55 (08) : 785 - 787
  • [37] Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome
    Tsukadaira, A
    Okubo, Y
    Kitano, K
    Horie, S
    Momose, T
    Takashi, S
    Suzuki, J
    Isobe, M
    Sekiguchi, M
    ALLERGY AND ASTHMA PROCEEDINGS, 1999, 20 (01) : 39 - 44
  • [38] Zafirlukast and Churg-Strauss syndrome
    Honsinger, RW
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24): : 1949 - 1949
  • [39] Montelukast and Churg-Strauss syndrome
    Donohue, JF
    CHEST, 2001, 119 (02) : 668 - 668
  • [40] Dermacase - Churg-Strauss syndrome
    Turchin, I
    Adams, SP
    CANADIAN FAMILY PHYSICIAN, 2003, 49 : 1449 - +